Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Raltegravir in HIV-HCV Coinfected Patients
NCT01231685Phase 2Completed
- Sponsor
- McGill University Health Centre
- Start
- Dec 2011
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by McGill University Health Centre. Started Dec 2011; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01231685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231685.